Johnson & Johnson (NYSE:JNJ) Receives New Coverage from Analysts at Credit Suisse Group

Share on StockTwits

Investment analysts at Credit Suisse Group started coverage on shares of Johnson & Johnson (NYSE:JNJ) in a research note issued on Friday, MarketBeat.com reports. The brokerage set an “outperform” rating and a $156.00 price target on the stock. Credit Suisse Group’s price target indicates a potential upside of 16.16% from the company’s current price.

Other research analysts have also issued research reports about the stock. Zacks Investment Research raised shares of Jack Henry & Associates from a “sell” rating to a “hold” rating in a research report on Wednesday, March 27th. Morgan Stanley set a $60.00 price target on shares of Berry Global Group and gave the stock a “hold” rating in a research report on Wednesday, April 17th. BMO Capital Markets initiated coverage on shares of Yelp in a research report on Wednesday, April 17th. They issued an “outperform” rating for the company. Barclays increased their price target on shares of from GBX 200 ($2.61) to GBX 210 ($2.74) and gave the stock an “equal weight” rating in a research report on Friday, June 21st. Finally, Wells Fargo & Co increased their price target on shares of Wingstop from $76.00 to $84.00 and gave the stock an “outperform” rating in a research report on Monday, May 6th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Johnson & Johnson presently has an average rating of “Buy” and an average target price of $149.89.

NYSE:JNJ opened at $134.30 on Friday. Johnson & Johnson has a 12-month low of $121.00 and a 12-month high of $148.99. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.44 and a quick ratio of 1.13. The firm has a market capitalization of $372.00 billion, a price-to-earnings ratio of 16.42, a PEG ratio of 2.42 and a beta of 0.70. The business has a 50-day simple moving average of $138.83.

Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings results on Tuesday, April 16th. The company reported $2.10 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.03 by $0.07. Johnson & Johnson had a net margin of 17.99% and a return on equity of 36.29%. The firm had revenue of $20.02 billion during the quarter, compared to analyst estimates of $19.55 billion. During the same quarter in the prior year, the business posted $2.06 earnings per share. The company’s quarterly revenue was up .1% compared to the same quarter last year. Equities research analysts expect that Johnson & Johnson will post 8.6 earnings per share for the current fiscal year.

In other news, Director Marillyn A. Hewson acquired 3,000 shares of the company’s stock in a transaction dated Tuesday, June 11th. The stock was bought at an average price of $139.68 per share, with a total value of $419,040.00. Following the completion of the acquisition, the director now owns 3,000 shares in the company, valued at approximately $419,040. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 0.23% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. UNIVEST FINANCIAL Corp grew its stake in shares of Johnson & Johnson by 0.5% during the second quarter. UNIVEST FINANCIAL Corp now owns 85,910 shares of the company’s stock valued at $11,966,000 after purchasing an additional 460 shares during the last quarter. West Oak Capital LLC grew its stake in shares of Johnson & Johnson by 1.4% during the second quarter. West Oak Capital LLC now owns 19,097 shares of the company’s stock valued at $2,660,000 after purchasing an additional 255 shares during the last quarter. 6 Meridian grew its stake in shares of Johnson & Johnson by 0.3% during the second quarter. 6 Meridian now owns 48,031 shares of the company’s stock valued at $6,690,000 after purchasing an additional 132 shares during the last quarter. Clark Capital Management Group Inc. grew its stake in shares of Johnson & Johnson by 3.5% during the second quarter. Clark Capital Management Group Inc. now owns 284,355 shares of the company’s stock valued at $39,605,000 after purchasing an additional 9,606 shares during the last quarter. Finally, Butensky & Cohen Financial Security Inc. grew its stake in shares of Johnson & Johnson by 6.7% during the second quarter. Butensky & Cohen Financial Security Inc. now owns 17,744 shares of the company’s stock valued at $2,471,000 after purchasing an additional 1,113 shares during the last quarter. 66.85% of the stock is owned by institutional investors.

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand.

Featured Article: The Role of a Fiduciary and Individual Investors

Analyst Recommendations for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Slack  Earns Neutral Rating from Analysts at Credit Suisse Group
Slack Earns Neutral Rating from Analysts at Credit Suisse Group
Slack  Coverage Initiated by Analysts at Morgan Stanley
Slack Coverage Initiated by Analysts at Morgan Stanley
Solaris Oilfield Infrastructure  Coverage Initiated by Analysts at Citigroup
Solaris Oilfield Infrastructure Coverage Initiated by Analysts at Citigroup
Tanger Factory Outlet Centers  Upgraded to “Hold” at Zacks Investment Research
Tanger Factory Outlet Centers Upgraded to “Hold” at Zacks Investment Research
Sterling Bancorp  Coverage Initiated at B. Riley
Sterling Bancorp Coverage Initiated at B. Riley
Restoration Hardware  Upgraded by ValuEngine to “Hold”
Restoration Hardware Upgraded by ValuEngine to “Hold”


© 2006-2019 Ticker Report